Dexamethasone: WHO tells countries to begin mass production of new COVID-19 drug
The World Health Organization (WHO) on Monday called for massive increase in production of dexamethasone.
Dexamethasone is an affordable steroid, which has proven effective in reducing deaths in critically ill COVID-19 patients.
WHO chief, Tedros Adhanom Ghebreyesus, told a virtual news conference that demand is no on increase, after a British trial of the drug became public.
Over 2,000 patients were administered the drug by Oxford University researchers and it brought down deaths rate by 35 percent among the most sickly.
“Although the data are still preliminary, the recent finding that the steroid dexamethasone has life-saving potential for critically ill COVID-19 patients gave us a much-needed reason to celebrate,” Tedros said.
“The next challenge is to increase production and rapidly and equitably distribute dexamethasone worldwide, focusing on where it is needed most,” he added.